查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522859

安瓿包装：市场占有率分析、产业趋势/统计、成长预测（2024-2029）

Ampoules Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 121 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

安瓿包装市场规模预计到2024年为50.8亿美元，预计到2029年将达到71.7亿美元，在预测期内（2024-2029年）复合年增长率为7.40%。

安瓿包装市场

主要亮点

  • 安瓿包装是保护产品免受外部污染的重要製造步骤。安瓿的特点是密封性高，能够确保产品包装的无菌性。製药业长期以来一直使用安瓿，尤其是玻璃安瓿作为主要包装解决方案。
  • 药品包装对防窜改包装的需求不断增加。因为药品包装的防篡改包装可确保患者收到在无菌环境中生产的原始、安全和有效形式的药物。对防篡改包装的需求不断增长正在推动成长。在此背景下，2023年3月，肖特在过去三年内投资了约7,500万欧元（8,100万美元），旨在扩大其在印度的药用玻璃产量。位于古吉拉突邦的工厂将成为硼硅酸玻璃管的製造地。硼硅酸玻璃管是一种可重新用于管瓶、安瓿和注射器等药物容器的材料，用于储存救生药物。
  • 此外，玻璃 100% 可回收，其品质在此过程中不会受到影响。这意味着大多数玻璃包装永远不会进入垃圾掩埋场，并且可以多次重复使用，而不会影响新产品的完整性。回收玻璃可以减少您的碳排放。与生产新玻璃相比，回收玻璃需要更少的原料和能源，因为它消除了采矿和精製步骤。此外，回收现有玻璃产品所需的能源少于熔化原料所需的能源。由于玻璃环保且可回收，需求预计会增加。
  • 塑胶安瓿的引入有助于缓解人们对破裂时玻璃碎片进入安瓿内容物的担忧。塑胶安瓿製造商将从中受益，但监管变化和标准可能会产生影响。此外，製药和生命科学最终用户对安瓿的需求极大地影响了他们的使用，因此市场仍然向这些最终用户倾斜，以应对需求的波动。

安瓿包装市场趋势

玻璃安瓿预计将占据很大的市场份额

  • 由于玻璃安瓿的碱性和耐水解性有限，玻璃是製药和个人护理行业的主要包装材料之一。玻璃高度透明，可以轻鬆看到内容物，而且由于相对不渗透空气和湿气，因此具有很强的保护性，并且对大多数药物具有化学耐受性。 Schott 等企业于 2023 年 3 月开始在印度生产琥珀色药用玻璃，以满足亚洲对安瓿、注射器和管瓶等药品容器不断增长的需求。
  • 安瓿在註射剂包装中扮演重要角色。老年人口的不断增长、慢性病盛行率的增加以及对注射治疗的日益偏好正在推动全球对注射剂包装的需求。此外，玻璃安瓿市场的公司推出高速填充线，以改善尺寸稳定的玻璃安瓿的功能并提高其製造能力。此外，Nipro Pharma Packaging 还承诺在未来三年内进行大量投资，以提高其在印度的产能。第一次扩建将为印度和全球市场生产更多玻璃管。
  • 全球快速成长的製药业正在推动市场成长。药用玻璃安瓿的需求源自印度、巴西和中国等人口稠密的经济体。药物产量的增加为患者在慢性发炎疾病的治疗中提供更多的舒适度和自主权正在推动市场成长。
  • 例如，2023年1月，专门从事类风湿性关节炎和新发炎性肠道疾病开发和製造的韩国生物製药公司Celltrion Healthcare自体免疫赢得向巴西卫生署。根据协议，Celltrion Healthcare 将向巴西供应 342,000 个安瓿。透过合作，国内药品製造商可以满足全球对关键药品不断增长的需求。 SGD Pharma 和 Corning Life Sciences 等公司正在共同努力，透过为客户进行在地化製造来支持持续的全球扩张。
  • 玻璃安瓿因其气密性和防篡改特性，广泛应用于製药业，用于包装疫苗和注射药物，确保内容物的无菌和完整性。乙型肝炎、结核病、水痘和脊髓灰质炎等疾病的疫苗接种支持了市场的成长，这些疾病需要适当储存疫苗。除药品外，玻璃安瓿还用于化妆品和化学工业，用于包装高纯度物质和精緻配方。

从长远来看，亚太地区预计将出现显着成长。

  • 中国製药业的成长预计将为该国安瓿创造成长机会。鼓励我国医药包装企业建立自主研发团队，探索创新、环保、安全、功能性、永续的包装材料和产品。药品製造领域的技术创新、合作研究、收购和生产扩张正在推动市场成长。
  • 德国特种玻璃製造商肖特最近在中国浙江省金云县开设了第一家药用玻璃管工厂。该公司进一步投资 7,000 万欧元（8,080 万美元）扩大其熔化基础设施，包括在 Gold Cloud 增加熔化罐，以满足初级药品包装对高品质玻璃管不断增长的需求。新坦克于2023年运作。
  • 护肤品需求的增加预计将推动市场成长。本地和国际品牌正在投资开发含有视黄醇的抗衰老、抗氧化、发炎、保湿、提视网醇胶原蛋白促进剂和快速见效的抗炎产品。此外，该地区的抗衰老化妆品类别包括乳霜、精华液、安瓶和眼霜。
  • 此外，根据中国国家统计局的数据，中国批发零售企业化妆品零售额从2019年的433亿美元增加到2023年的约585.3亿美元。美容安瓶提供高浓缩、有针对性的护肤护理，针对保湿、抗衰老、提亮等问题。中国化妆品零售的成长可能会对未来几年的安瓿需求产生正面影响。

安瓿包装产业概况

安瓿包装市场较为分散。政府倡议的激增以及对注射剂和其他药品的需求不断增加，为安瓿包装市场提供了利润丰厚的机会。整体而言，现有企业之间的竞争非常激烈。不同製药业大公司的扩张和合併预计将增加对安瓿包装的需求。市场上的主要企业是 Schott AG、Amposan SA 和 Gerresheimer AG。

  • 2023 年 12 月 - 肖特製药宣布计划扩大其全球製造网络，并决定投资两位数百万欧元在塞尔维亚中部雅戈丁那建立一个新的药物封装解决方案和输送系统製造製造地。製药业安瓿生产预计将于 2024 年推出。
  • 2023 年 9 月 - 年轻的法国香水品牌 Ormaie 决定在其香水中仅使用 100% 天然成分，并推出了一系列带有玻璃安瓿的小尺寸可再填充瓶。 Ormaie 的 9 款香水系列填充用，可在家中或旅途中使用。 Ormaie 提出了一种时尚且环保的补充系统的创新解决方案。 Ormaie 现在提供填充用的玻璃安瓿瓶，其中装有相同尺寸的香水，而不是传统的再填充系统。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 产业价值链分析
  • 产业吸引力－波特五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第五章市场动态

  • 市场驱动因素
    • 对砸道机窜改药品包装的需求
    • 提高可回收玻璃的产品价值
    • 政府法规和标准
  • 市场限制因素
    • 对倾倒使用过的安瓿的担忧

第六章 市场细分

  • 按材质
    • 玻璃
    • 塑胶
  • 按最终用户产业
    • 药品
    • 个人护理/化妆品
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 法国
      • 德国
      • 义大利
      • 西班牙
    • 亚洲
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲/纽西兰
    • 拉丁美洲
      • 巴西
      • 墨西哥
    • 中东/非洲
      • 沙乌地阿拉伯
      • 埃及
      • 阿拉伯聯合大公国
      • 南非

第七章 竞争格局

  • 公司简介
    • Schott AG
    • Gerresheimer AG
    • Stevanato Group
    • ESSCO Glass
    • AAPL Solutions
    • Global Pharmatech Pvt Ltd
    • James Alexander Corporation
    • Nipro Pharma Packaging International NV
    • SGD Pharma
    • Shandong Pharmaceutical Glass Co. Ltd

第八章投资分析

第9章市场的未来

简介目录
Product Code: 51029

The Ampoules Packaging Market size is estimated at USD 5.08 billion in 2024, and is expected to reach USD 7.17 billion by 2029, growing at a CAGR of 7.40% during the forecast period (2024-2029).

Ampoules Packaging - Market

Key Highlights

  • Ampoules packaging is an essential procedure in manufacturing to protect the product from external contamination. Ampoules are unique because they seal and ensure an aseptic condition factor for the product packaging. The pharmaceutical industry has been using ampoules, especially glass, for a very long period as a primary packaging solution.
  • The demand for tamper-proof packaging for pharmaceutical packaging is growing, as tamper-proof packaging in pharmaceutical products ensures that the patient receives the drug in its original, safe, and effective form as it was manufactured in a sterile environment. The increasing demand for tamper-proof packaging has propelled growth. In reference to this, in March 2023, Schott invested around EUR 75 million (USD 81 million) over the last three years with an aim to expand its pharma glass production in India. The Gujarat-based facility emerges as the company's manufacturing hub for borosilicate glass tubing, a material converted to pharmaceutical containers, such as vials, ampoules, or syringes, to store life-saving drugs.
  • Additionally, glass is 100% recyclable, and the process does not compromise the quality. It means that most glass packaging never ends up in a landfill and can be reused many times without compromising the integrity of the new product. Glass recycling reduces the carbon footprint. Recycling glass requires fewer raw materials and less energy compared to producing new glass, as it avoids the mining and refining processes. Moreover, the energy required to recycle existing glass products is less than that needed to melt the raw materials. It is eco-friendly and recyclable in nature, which is expected to boost the demand.
  • The advent of plastic ampoules in the market has helped ease some of the concerns related to glass fragments getting into the contents of the ampoules during breakage. Manufacturers of plastic ampoules will benefit from this, but regulatory changes and standards may impact them. Additionally, since the demand for ampoules from the pharmaceutical and life sciences end users significantly impacts their usage, the market remains inclined toward these end users for demand variations.

Ampoules Packaging Market Trends

Glass Ampoules are Expected to Hold a Significant Share in the Market

  • Glass is one of the primary packaging materials for the pharmaceutical and personal care industry, as it limits the alkalinity and hydrolytic resistance of glass ampoules. It offers high transparency, enabling easy inspection of their contents, and higher protection because they are relatively impermeable to air and moisture and chemically resistant to most medicinal products. Players such as Schott launched the production of amber pharma glass in India to meet the increasing demand for pharmaceutical containers, such as ampoules, syringes or vials, and other drugs in Asia, in March 2023.
  • Ampoules play a significant role in parenteral packaging. The growing geriatric population, increasing prevalence of chronic diseases, and rising preference for injection-based treatments drive the global demand for parenteral packaging. Further, players operating in the glass ampoules market are launching high-speed filling lines to improve the functionalities of glass ampoules with highly stable dimensional qualities, increasing their manufacturing capabilities. Further, Nipro Pharma Packaging has pledged to invest substantially in a capacity extension in India in the coming three years. The first expansion will produce additional glass tubing quantities for the Indian and global markets.
  • The rapidly growing pharmaceutical industry worldwide is driving the market's growth. The demand for pharmaceutical glass ampoules is emerging from densely populated economies such as India, Brazil, and China. Increasing medication production to offer patients greater comfort and autonomy in treating chronic inflammatory diseases propels the market's growth.
  • For instance, in January 2023, South Korean biopharmaceutical company Celltrion Healthcare, specializing in the development and production of biosimilars and new molecules, won a tender to supply the Ministry of Health in Brazil, with infliximab, used for the treatment of 8 autoimmune diseases, including Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease (IBD). As per the contract, Celltrion Healthcare intends to supply 342,000 ampoules to Brazil. The players collaborate in their efforts, enabling domestic drug makers to meet the rising demand for critical medicines globally. Players such as SGD Pharma and Corning Life Sciences have collaborated to support their continued global expansion as the companies localize manufacturing for their customers.
  • Glass ampoules are extensively used in the pharmaceutical industry for packaging vaccines and injectable medications due to their airtight and tamper-evident properties, ensuring the sterility and integrity of the contents. The market's growth is supported by vaccination for diseases such as Hepatitis B, tuberculosis, Chicken Pox, and Polio, which require proper vaccine storage. Beyond pharmaceuticals, glass ampoules are also used in the cosmetics and chemical industries to package high-purity substances and sensitive formulations.

Asia-Pacific is Expected to Show a Significant Growth in the Long Term

  • The growth of the Chinese pharmaceutical sector is expected to create growth opportunities for ampoules in the country. Chinese pharmaceutical packaging companies are encouraged to develop independent research and development teams to explore innovative, environmentally friendly, safe, functional, and sustainable packaging materials and products. The growing innovation, collaboration, acquisition, and production in drug manufacturing have boosted the market growth.
  • Schott, a Germany-based specialty glass manufacturer, recently opened its first pharma glass tubing factory in Jinyun County, Zhejiang province, China. The company invested another EUR 70 million (USD 80.8 million) to expand its melting infrastructure, including additional melting tanks in Jinyun, to meet the rising demand for high-quality glass tubing for primary pharmaceutical packaging. The new tanks were operational in 2023.
  • Increasing demand for skin care products is expected to boost the market's growth. Domestic and foreign brands invest in developing products with anti-aging, antioxidants, anti-inflammatory, hydration, brightening collagen boosters with retinol, and de-puffing properties that deliver rapid results. Furthermore, the category of anti-aging cosmetics in the region will include creams, serums, ampoules, and eye creams.
  • Moreover, according to the National Bureau of Statistics of China, the retail sales of cosmetics by wholesale and retail companies in China totaled about USD 58.53 billion in 2023 from USD 43.30 billion in 2019. Ampoules in cosmetics provide highly concentrated, targeted skincare treatments that address concerns like hydration, anti-aging, or brightening. The growth in retail sales of cosmetics products in China can positively impact the demand for ampoules in the coming years.

Ampoules Packaging Industry Overview

The ampoules packaging market is fragmented. The surge in government initiatives and increasing demand for injectables and other medicines provide lucrative opportunities in the ampoules packaging market. Overall, the competitive rivalry among existing competitors is high. Expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand for ampoule packaging. Key players in the market are Schott AG, Amposan SA, and Gerresheimer AG.

  • December 2023 - SCHOTT Pharma announced plans to expand its global manufacturing network and decided to invest a double-digit million Euro amount in a new production site for pharmaceutical drug containment solutions and delivery systems in Jagodina in central Serbia. The ramp-up for the manufacturing of ampoules for the pharmaceutical industry is expected to start in 2024.
  • September 2023 - Ormaie, a young French fragrance brand, decided to use only 100% natural ingredients in its fragrances and launched a collection of small-size refillable bottles using a glass ampoule. Ormaie's collection of nine perfumes is available in refillable 20ml formats, perfect for use at home or on the go. Ormaie has come up with an innovative solution for a refillable system that's both stylish and eco-friendly. Instead of traditional refillable systems, Ormaie now offers refillable glass ampoules that are the same size and filled with perfumes.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Value-Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Demand for Tamper-proof Pharmaceutical Product Packaging
    • 5.1.2 Commodity Value of Glass Increased with Recyclability
    • 5.1.3 Government Regulations and Standards
  • 5.2 Market Restraints
    • 5.2.1 Concerns Regarding Dumping Used Ampoules

6 MARKET SEGMENTATION

  • 6.1 By Material
    • 6.1.1 Glass
    • 6.1.2 Plastic
  • 6.2 By End-user Industry
    • 6.2.1 Pharmaceutical
    • 6.2.2 Personal Care and Cosmetic
  • 6.3 By Region ***
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 France
      • 6.3.2.3 Germany
      • 6.3.2.4 Italy
      • 6.3.2.5 Spain
    • 6.3.3 Asia
      • 6.3.3.1 China
      • 6.3.3.2 India
      • 6.3.3.3 Japan
      • 6.3.3.4 South Korea
      • 6.3.3.5 Australia and New Zealand
    • 6.3.4 Latin America
      • 6.3.4.1 Brazil
      • 6.3.4.2 Mexico
    • 6.3.5 Middle East and Africa
      • 6.3.5.1 Saudi Arabia
      • 6.3.5.2 Egypt
      • 6.3.5.3 United Arab Emirates
      • 6.3.5.4 South Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Schott AG
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Stevanato Group
    • 7.1.4 ESSCO Glass
    • 7.1.5 AAPL Solutions
    • 7.1.6 Global Pharmatech Pvt Ltd
    • 7.1.7 James Alexander Corporation
    • 7.1.8 Nipro Pharma Packaging International NV
    • 7.1.9 SGD Pharma
    • 7.1.10 Shandong Pharmaceutical Glass Co. Ltd

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET